Tile

STAT Feeds

Exploring health and medicine for a decade.

337 feeds
Loading tags...
Tile
https://www.statnews.com/category/the-regulars/pharmalot/feed/ RSS

STAT Pharmalot: Insight and analysis by Ed Silverman

<a href="https://www.statnews.com/staff/ed-silverman/">Ed Silverman</a> began writing Pharmalot at The Star Ledger of New Jersey in 2007 and it continues to this day at STAT. He joined STAT at its founding in 2015, coming from the Wall Street Journal. He has covered the pharmaceutical industry since 1995.
Last seen 5 days ago 6 views
Tile
https://en.ilsole24ore.com/rss/casa--architettura.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 2 views
Tile
https://en.ilsole24ore.com/rss/casa--protagonisti.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago
Tile
https://statusgator.com/blog/category/integrations/feed/ RSS

Integrations Archives | StatusGator

StatusGator Blog
Last seen 3 weeks ago 17 views
Tile
https://www.nist.gov/news-events/Mathematics%20and%20Statistics/rss.xml RSS

News and Events Feed by Topic

Last seen 1 month ago 7 views
Tile
https://blog.playstation.com/2025/05/05/playstation-store-april-2025s-top-downloads/feed/ RSS

Comments on: PlayStation Store: April 2025’s top downloads

Official PlayStation Blog for news and video updates on PlayStation, PS5, PS4, PS VR, PlayStation Plus and more.
Last seen 2 weeks ago 4 views
Tile
https://en.ilsole24ore.com/rss/casa--finanza-immobiliare.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 7 views
Tile
https://statusgator.com/blog/category/early-warning-signals/feed/ RSS

Early Warning Signals Archives | StatusGator

StatusGator Blog
Last seen 3 weeks ago 31 views
Tile
https://claudestatus.com/rss.xml RSS

Claude Status

Real-time status updates for Claude services
Last seen 1 month ago 13 views
Tile
https://statusgator.com/blog/feed/ RSS

StatusGator

StatusGator Blog
Last seen 3 weeks ago 14 views
Tile
https://en.ilsole24ore.com/rss/casa--design.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 2 views
Tile

View full article
Tile
Select a feed to view its content

Loading feed entries...

STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

STAT+: Virginia governor vetoes legislation to create an advisory panel to lower the cost of prescription drugs

STAT+: Virginia governor vetoes legislation to create an advisory panel to lower the cost of prescription drugs

STAT+: Canadian medical societies lack sufficient conflict-of-interest policies, study finds

STAT+: Canadian medical societies lack sufficient conflict-of-interest policies, study finds

STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more

STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more

STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more

STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more

STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more

STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more

STAT+: CDC plans to transfer monkeys to nonprofit’s sanctuary as it seeks to reduce animal testing

STAT+: CDC plans to transfer monkeys to nonprofit’s sanctuary as it seeks to reduce animal testing

STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more

STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more

STAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.

STAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.

STAT+: Maryland state affordability board places a price cap on Ozempic

STAT+: Maryland state affordability board places a price cap on Ozempic

STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more

STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more

STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

STAT+: Up and down the ladder: The latest comings and goings

STAT+: Up and down the ladder: The latest comings and goings

STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more

STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more

STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington

STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington

STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors

STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors

STAT+: Up and down the ladder: The latest comings and goings

STAT+: Up and down the ladder: The latest comings and goings

STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more

STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more